Alignment Healthcare (NASDAQ:ALHC) Downgraded by KeyCorp to Sector Weight

Alignment Healthcare (NASDAQ:ALHC) was downgraded by investment analysts at KeyCorp from an “overweight” rating to a “sector weight” rating in a research note issued on Friday, MarketBeat Ratings reports.

Several other research firms also recently weighed in on ALHC. JPMorgan Chase & Co. dropped their price target on Alignment Healthcare from $22.00 to $10.00 and set an “overweight” rating on the stock in a research note on Friday, October 9th. Needham & Company LLC began coverage on Alignment Healthcare in a report on Wednesday. They set a “hold” rating for the company. Raymond James Financial reiterated an “outperform” rating on shares of Alignment Healthcare in a research report on Monday, October 12th. Scotiabank set a $9.00 price target on shares of Alignment Healthcare in a report on Friday, October 9th. Finally, The Goldman Sachs Group reissued a “buy” rating and set a $12.00 price target on shares of Alignment Healthcare in a research report on Thursday, October 22nd. Six analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat, Alignment Healthcare presently has a consensus rating of “Hold” and a consensus target price of $15.91.

Alignment Healthcare Trading Down 1.5%

NASDAQ:ALHC opened at $8.06 on Friday. Alignment Healthcare has a 12 month low of $6.01 and a 12 month high of $25.12. The firm has a fifty day simple moving average of $9.99 and a 200-day simple moving average of $16.89. The company has a current ratio of 1.70, a quick ratio of 1.70 and a debt-to-equity ratio of 1.22. The company has a market capitalization of $1.67 billion, a P/E ratio of 42.42 and a beta of 1.14.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings data on Thursday, October 29th. The company reported ($0.04) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.04). Alignment Healthcare had a net margin of 0.89% and a return on equity of 20.02%. The firm had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.31 billion. During the same period in the previous year, the company earned $0.02 earnings per share. The business’s quarterly revenue was up 36.7% compared to the same quarter last year. On average, equities research analysts anticipate that Alignment Healthcare will post 0.14 earnings per share for the current year.

Insider Buying and Selling

In other Alignment Healthcare news, CEO John Kao sold 27,400 shares of Alignment Healthcare stock in a transaction dated Monday, September 14th. The stock was sold at an average price of $13.00, for a total transaction of $356,200.00. Following the completion of the transaction, the chief executive officer owned 590,766 shares in the company, valued at approximately $7,679,958. This trade represents a 4.43% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Joseph Konowiecki sold 23,511 shares of the business’s stock in a transaction dated Thursday, September 17th. The shares were sold at an average price of $8.61, for a total value of $202,429.71. Following the completion of the transaction, the executive vice president directly owned 1,080,305 shares of the company’s stock, valued at approximately $9,301,426.05. This trade represents a 2.13% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 1,061,967 shares of company stock valued at $13,642,490 over the last quarter. 5.20% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of ALHC. PNC Financial Services Group Inc. boosted its position in Alignment Healthcare by 9.2% in the 1st quarter. PNC Financial Services Group Inc. now owns 11,445 shares of the company’s stock worth $202,000 after purchasing an additional 962 shares in the last quarter. GAMMA Investing LLC increased its holdings in shares of Alignment Healthcare by 46.6% during the 2nd quarter. GAMMA Investing LLC now owns 3,368 shares of the company’s stock valued at $80,000 after purchasing an additional 1,070 shares in the last quarter. Versant Capital Management Inc increased its holdings in shares of Alignment Healthcare by 463.3% during the 2nd quarter. Versant Capital Management Inc now owns 1,380 shares of the company’s stock valued at $33,000 after purchasing an additional 1,135 shares in the last quarter. Nykredit A S acquired a new position in shares of Alignment Healthcare in the 2nd quarter valued at $36,000. Finally, Strs Ohio lifted its stake in shares of Alignment Healthcare by 10.2% in the 1st quarter. Strs Ohio now owns 24,900 shares of the company’s stock valued at $439,000 after purchasing an additional 2,300 shares during the period. 86.19% of the stock is owned by institutional investors and hedge funds.

Key Headlines Impacting Alignment Healthcare

Here are the key news stories impacting Alignment Healthcare this week:

• Positive Sentiment: Third-quarter revenue reached $1.36 billion, exceeding the $1.31 billion analyst consensus and increasing 36.7% year over year. The company’s quarterly loss of $0.04 per share matched expectations. Alignment Healthcare Reports Third Quarter 2026 Results
• Positive Sentiment: Management said it expects at least 20% top-line growth in 2027, supporting the company’s longer-term expansion story. Alignment 2027 Growth Outlook
• Neutral Sentiment: The earnings release and conference call showed continued revenue momentum, but the quarter remained unprofitable, with results declining from earnings of $0.02 per share in the prior-year period. Alignment Healthcare Q3 2026 Earnings Call Transcript
• Negative Sentiment: Alignment lowered its 2026 adjusted EBITDA outlook to no less than $100 million. The reduced profitability forecast appears to outweigh the revenue beat because it raises concerns about margins and near-term earnings quality. Alignment Healthcare Q3 Guidance
• Negative Sentiment: Bleichmar Fonti & Auld LLP announced an investigation into potential securities fraud related to allegations of inflated EBITDA. The announcement is not a finding of wrongdoing, but it adds legal and reputational risk after the stock’s significant decline and may increase volatility. ALHC Securities Investigation Announcement

About Alignment Healthcare

Alignment Healthcare, Inc is a technology-enabled health insurance company focused on providing Medicare Advantage plans for seniors. The company combines health plan coverage with care coordination and clinical services designed to help members manage chronic conditions, access providers and navigate the health care system.

Its offerings include Medicare Advantage plans, supplemental benefits and member support services. Alignment also uses its proprietary technology platform, including the Alignment Virtual Application (AVA), to support care teams, analyze health information and help deliver more personalized services to members.

Founded in 2013, Alignment Healthcare serves Medicare-eligible consumers in selected markets, including California, Florida, Nevada and North Carolina.